Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer

• Status: Completed
• Trial end date: 2015-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study will determine if hormone receptor positive premenopausal metastatic breast cancer patients who undergo removal of the ovaries in mid-luteal versus mid-follicular phase have a longer survival.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: International Breast Cancer Research Foundation
• Collaborator: Breast Cancer Research Foundation
• Treatments: Hormones; Tamoxifen

Criteria

Inclusion Criteria:

• Estrogen receptor or progesterone receptor positive breast cancer

• Premenopausal with regular menstrual cycles

Exclusion Criteria:

• Current oral contraceptives